Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

Young Jip Kim, Kichan Kim, Sun Hyuk Hwang, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho

Clin Mol Hepatol. 2013;19(3):300-304. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.300

View: 8361 Download: 87 Crossref: 27

Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients

Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun

Clin Mol Hepatol. 2011;17(4):261-267. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.261

View: 7221 Download: 52 Crossref: 10

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin

Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol

Clin Mol Hepatol. 2011;17(3):183-188. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.183

View: 7913 Download: 39 Crossref: 3

Editorial

Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response

Jeong Heo

Clin Mol Hepatol. 2011;17(3):180-182. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.180

View: 6915 Download: 34

The Korean Journal of Hepatology Elsewhere

Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin

Kyung-Ah Kim

Clin Mol Hepatol. 2011;17(1):84-86. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.84

View: 6139 Download: 39 Crossref: 1

3

Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients

Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo

Clin Mol Hepatol. 2009;15(1):52-58. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.52

View: 4992 Download: 21

Long - term Efficacy and Durability of Lamivudine Therapy in Patients with Chronic Hepatitis B

Chae Yoon Chon,Sang Hoon Ahn,Kwang Hyub Han,Young Myoung Moon,Sung Pil Hong,Yong Han Paik,Byung Soo Moon

Clin Mol Hepatol. 2001;7(4):423-431. Published online January 1, 1970

View: 2663 Download: 14

1 |

Viewed By 8481	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7419	MAFLD: How is it different from NAFLD?
Viewed By 5379	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5008	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4550	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 291	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search